[Kanzhun Ltd.(BZ US, SELL, TP US$14.5) TP Change]: Growth Target Cannot Justify High Valuation
371 Views21 Nov 2023 09:12
- BZ reported 3Q23 cash billing 0.8% higher than our est., revenue beat our estimate/consensus 5.2%/3.8%, non-GAAP NI beat our estimate/consensus by 103%/50%.
- Cost saving and investment income are the main reasons for bottom-line beat, which we think are not sustainable.
- Even BZ can deliver its “3 years with 100mn new users” target until 2025, we think its 20% earnings CAGR in 2023-25E still cannot justify its high valuation (TBC)
Top Unpaywalled Insights
More »Discussions
(Paid Plans Only)